Filing Details
- Accession Number:
- 0001209191-19-032858
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-28 06:01:11
- Reporting Period:
- 2019-05-23
- Accepted Time:
- 2019-05-28 06:01:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 949858 | Achieve Life Sciences Inc. | ACHV | In Vitro & In Vivo Diagnostic Substances (2835) | 954343413 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1713369 | Alistair Richard Stewart | 520 Pike Street Suite 2250 Seattle WA 98101 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-23 | 17,500 | $3.61 | 212,530 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 7,186 | Indirect | By Spouse |
| Common Stock | 17,641 | Indirect | By Ricanto Limited |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6016 to $3.61 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reporting holder is a principal owner of Ricanto Limited.
Billionaire Hedge Funds
